Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(10%)
Results Posted
25%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
6
60%
Ph phase_1
1
10%
Ph phase_4
3
30%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
6(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(4)
Terminated(3)
Other(2)

Detailed Status

Completed4
unknown2
Withdrawn2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 43 (30.0%)
N/A6 (60.0%)

Trials by Status

completed440%
recruiting110%
terminated110%
unknown220%
withdrawn220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10